Oncorus Inc. (ONCR) Fundamentals

Oncorus Inc is a clinical-stage biopharmaceutical company focused on developing viral immunotherapies to transform outcomes for cancer patients. The company is in the process of developing intratumorally and intravenously administered product candidates designed to selectively attack and kill tumor cells and stimulate multiple arms of the immune system against tumors. Its pipeline product includes ONCR-177; ONCR-GBM; Coxsackievirus A21 and Seneca Valley Virus.
SHARE INFORMATION
Market Cap$ 39,219,434
Shares Outstanding25,973,135
Float20,002,451
Percent Float77.01%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -2.55
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions139
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months932,601
Institutional Holdings Percent76.8%
Institutional Sold Previous 3 Months3,528,330
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months386,500
Insider Holdings Percent2.0
Insider Sold Previous 3 Months-
Insider Shares Owned521,358
TRADING INFO
52 Week High$ 13.41
52 Week Low$ 0.98
52 Week High Change$ -88.66
21 Day Moving Average$ 1.4057
21 Day Extended Moving Average$ 1.4152
50 Day Moving Average$ 1.3998
50 Day Extended Moving Average$ 1.4154
200 Day Moving Average$ 3.1039
200 Day Extended Moving Average$ 3.7143
10 Day Average Volume77,307
20 Day Average Volume61,754
30 Day Average Volume61,279
50 Day Average Volume234,088
Alpha-0.118631
Beta2.9239
Standard Deviation0.259127
R20.344017
7 Day Price Change$ -0.01
7 Day Percent Change-0.66%
21 Day Price Change$ 0.16
21 Day Percent Change11.85%
30 Day Price Change$ 0.22
30 Day Percent Change17.05%
Month to Date Price Change$ 0.21
Month to Date Percent Change16.15%
Quarter to Date Price Change$ 0.25
Quarter to Date Percent Change19.84%
180 Day Price Change$ -1.20
180 Day Percent Change-44.28%
200 Day Price Change$ -2.12
200 Day Percent Change-58.4%
Year to Date Price Change$ -3.76
Year to Date Percent Change-71.35%

Oncorus Inc. (ONCR) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.40
Total Debt To Equity0.70
Int Coverage0.00
Current Ratio6.40
Leverage Ratio1.60
Quick Ratio6.30
Long Term Debt To Capital0.41
VALUATION MEASURES
PE Ratio-0.50
Enterprise Value$ 8,328,777
Price to Sales0.00
Price to Free Cash-0.50
PE High Last 5 Years0.00
Price To Book0.40
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-36.89
Return on Equity-56.36
Return on Capital-39.21

Oncorus Inc. (ONCR) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOTheodore Ashburn
Emplyoees82
Last AuditUQ
CIK0001671818
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address50 Hampshire Street
Suite 401
Cambridge, MA 2139
Websitehttps://www.oncorus.com
Facsimile-
Telephone+1 857 320-6400
Emailinfo@oncorus.com


Your Recent History
NASDAQ
ONCR
Oncorus
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.